Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 172
Number of items: 172
  • Open Access
    Raaphorst, J., van Tol, M. J., Groot, P. F. C., Altena, E., van der Werf, Y. D., Majoie, C. B., van der Kooi, A. J., van den Berg, L. H., Schmand, B., de Visser, M., & Veltman, D. J. (2014). Prefrontal involvement related to cognitive impairment in progressive muscular atrophy. Neurology, 83(9), 818-825. https://doi.org/10.1212/WNL.0000000000000745
  • Open Access
    Olde Dubbelink, K. T. E., Hillebrand, A., Twisk, J. W. R., Deijen, J. B., Stoffers, D., Schmand, B., Stam, C. J., & Berendse, H. W. (2014). Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers. Neurology, 82(3), 263-270. https://doi.org/10.1212/WNL.0000000000000034
  • Schmand, B. A., Murre, J. M. J., Huizenga, H. M., Agelink van Rentergem Zandvliet, J. A., & de Vent, N. R. (2013). Advanced Neuropsychological Diagnostics Infrastructure (ANDI). Web publication or website, Universiteit van Amsterdam. http://www.andi.nl/home-page/
  • Kylstra, W. A., Aaronson, J. A., Hofman, W. F., & Schmand, B. A. (2013). Neuropsychological functioning after CPAP treatment in obstructive sleep apnea: a meta-analysis. Sleep Medicine Reviews, 17(5), 341-347. https://doi.org/10.1016/j.smrv.2012.09.002
  • Schouw, M. L. J., Caan, M. W. A., Geurts, H. M., Schmand, B., Booij, J., Nederveen, A. J., & Reneman, L. (2013). Monoaminergic dysfunction in recreational users of dexamphetamine. European Neuropsychopharmacology, 23(11), 1491-1502. https://doi.org/10.1016/j.euroneuro.2013.01.005
  • Rienstra, A., Groot, P. F. C., Spaan, P. E. J., Majoie, C. B. L. M., Nederveen, A. J., Walstra, G. J. M., de Jonghe, J. F. M., van Gool, W. A., Olabarriaga, S. D., Korkhov, V. V., & Schmand, B. (2013). Symptom validity testing in memory clinics: Hippocampal-memory associations and relevance for diagnosing mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology, 35(1), 59-70. https://doi.org/10.1080/13803395.2012.751361
  • Odekerken, V. J. J., van Laar, T., Staal, M. J., Mosch, A., Hoffmann, C. F. E., Nijssen, P. C. G., Beute, G. N., Vugt, J. P. P., Lenders, M. W. P. M., Contarino, M. F., Mink, M. S. J., Bour, L. J., van den Munckhof, P., Schmand, B. A., de Haan, R. J., Schuurman, P. R., & de Bie, R. M. A. (2013). Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurology, 12(1), 37-44. https://doi.org/10.1016/S1474-4422(12)70264-8
  • Raaphorst, J., Beeldman, E., Jaeger, B., Schmand, B., van den Berg, L. H., Weikamp, J. G., Schelhaas, H. J., de Visser, M., & de Haan, R. J. (2013). Is the Frontal Assessment Battery reliable in ALS patients? Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(1), 73-74. https://doi.org/10.3109/17482968.2012.712974
  • Goudsmit, M., Parlevliet, J. L., van Campen, J. P. C. M., & Schmand, B. (2013). Diagnosis of dementia in non-western elderly migrants in memory clinics: Obstacles and solutions. Tijdschrift voor Gerontologie en Geriatrie, 42(5), 204-214.
  • Raaphorst, J., Beeldman, E., Schmand, B., van den Berg, L. H., de Visser, M., & de Haan, R. J. (2013). Response to ‘Exploring limits of neuropsychological screening in ALS: The FAB problem’. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(2), 159-160. https://doi.org/10.3109/21678421.2012.747541
Page 8 of 18